comparemela.com

Latest Breaking News On - Institute for clinical - Page 20 : comparemela.com

FDA advisers consider MDMA therapy to treat PTSD

(CNN) — A federal advisory committee meets today to weigh the risks and benefits of using MDMA, commonly known as ecstasy, as a treatment for post-traumatic stress disorder.

United statesJon alpertRachel yehudaAmy emersonJoshua gordonAlbert einstein college of medicineAmerican psychiatric associationDrug administrationInstitute for clinicalPsychopharmacologic drugs advisory committeeNational centerNational institute of mental healthControlled substances actEconomic reviewNational instituteTrauma research

FDA advisors express skepticism as they debate MDMA therapy for PTSD

A panel of advisors to the FDA voted against the potential use of MDMA for treating PTSD.

Elizabeth joniakWalter dunnMaryann amirshahiBerra yazar klosinskiKim witczakDavid millisInstitute for clinicalGeorgetown universityDrug administrationLykos therapeuticsAlia liliensteinElizabeth joniak grantEconomic review

FDA advisors express skepticism as they debate MDMA therapy for PTSD

A panel of advisors to the FDA voted against the potential use of MDMA for treating PTSD.

Berra yazar klosinskiKim witczakMaryann amirshahiDavid millisElizabeth joniakWalter dunnInstitute for clinicalGeorgetown universityDrug administrationLykos therapeuticsAlia liliensteinElizabeth joniak grantEconomic review

Panel rejects psychedelic drug MDMA as PTSD treatment in possible setback for advocates

Federal health advisers voted Tuesday against a first-of-a-kind proposal to begin using the mind-altering drug MDMA as a treatment for PTSD.

United statesElizabeth joniakMelissa decker baroneRajesh narendranDepartment of veterans affairsInstitute for clinicalUniversity of pittsburghMultidisciplinary association for psychedelicDrug administrationElizabeth joniak grantEconomic reviewMultidisciplinary associationPsychedelic studies

Panel Rejects Psychedelic Drug MDMA as PTSD Treatment in Possible Setback for Advocates

The experts cited flawed study data and potential safety risks of MDMA, including heart problems.

Melissa decker baroneRajesh narendranElizabeth joniakUniversity of pittsburghInstitute for clinicalMultidisciplinary association for psychedelicAssociated pressDepartment of veterans affairsDrug administrationElizabeth joniak grantEconomic reviewMultidisciplinary associationPsychedelic studies

vimarsana © 2020. All Rights Reserved.